This innovative direct dissolution hydrogen delivery system successfully maintains high and stable H₂ concentrations in dialysate (approximately 230 ppb in final dialysate) with efficient diffusion into the extracorporeal blood circuit, though significant pulmonary clearance limits systemic delivery. The system demonstrates superior H₂ concentration stability compared to conventional electrolysis methods with simpler design and lower installation costs, suggesting potential feasibility for widespread clinical adoption in hemodialysis settings. Future investigations using hemodiafiltration techniques are needed to enhance systemic hydrogen bioavailability and establish long-term clinical therapeutic benefits in renal disease management.
Plain-Language Summary
Researchers developed a new system that dissolves hydrogen gas directly into water used during kidney dialysis (a treatment that filters waste from blood). In a test with one dog, the system successfully maintained high and stable levels of hydrogen in the dialysis fluid. The hydrogen moved efficiently from the dialysis fluid into the blood being treated, but most of it was cleared by the lungs before reaching the rest of the body, suggesting it mainly worked where the blood and dialysis fluid met.
Abstract
Hydrogen gas (H₂) shows broad therapeutic potential. Hemodialysis, using large dialysate volumes in contact with blood, presents a promising H₂ delivery method. We developed an innovative system generating hydrogen-enriched dialysate, differing from conventional electrolysis. This system directly dissolves H₂ gas into tap water to produce saturated water, which then undergoes reverse osmosis (RO) for dialysate preparation. Using this system in a canine hemodialysis model with a single dog, we measured H₂ concentrations. High H₂ levels were consistently maintained (approximately 1,600 ppb in RO water; stable approximately 230 ppb in final dialysate). H₂ efficiently diffused into the extracorporeal blood circuit, with outlet concentrations reaching 54.0-67.7% of the dialysate level. However, low systemic arterial concentrations (pulmonary, carotid) indicated significant pulmonary clearance, suggesting H₂ primarily acts locally within the circuit and dialyzer. Compared with traditional electrolyzed water methods, this direct dissolution system delivers substantially higher and more stable H₂ concentrations. Its simpler design and potentially lower installation costs suggest feasibility for widespread clinical adoption. Future studies should explore hemodiafiltration (HDF) to potentially enhance systemic H₂ delivery and evaluate long-term clinical benefits.
